PMA supplement
P810025 S020: AMVISC/AMVISC PLUS SODIUM HYALURONATE
FDA PMA supplement · Normal 180 Day Track · Bausch & Lomb, Inc.
Key facts
| Original PMA | P810025 |
|---|---|
| Supplement number | S020 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Express GMP Supplement |
| Trade name | AMVISC/AMVISC PLUS SODIUM HYALURONATE |
| Generic name | AID, SURGICAL, VISCOELASTIC |
| Applicant | Bausch & Lomb, Inc. |
| Product code | LZP |
| Received date | Mar 22, 2002 |
| Decision date | Jul 19, 2002 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: